The Medigen COVID-19 vaccine is not recognized by Japan, complicating travel plans to the country by those who have received it.
The Central Epidemic Command Center has confirmed reports that Medigen is willing to pay for vaccine recipients’ polymerase chain reaction (PCR) tests, which Japan requires from those who have not received a recognized vaccine. This would set people’s minds at rest, restore the drugmaker’s reputation and fulfill the public’s expectations.
To enable Medigen recipients to travel to Japan without taking a PCR test in advance, the government allows them to receive three doses of another, internationally recognized vaccine.
As reasonable as this might seem, it is a risky solution, as people would receive up to six doses in total, which is obviously far from ideal. Nobody can be sure whether there would be any repercussions.
If it turns out that there are adverse effects of doubling up vaccinations, who should be held accountable? No one would want to take responsibility.
Many Taiwanese who have received three Medigen doses are genuinely supportive of the drugmaker. They were ridiculed, but they did not waver. Regardless of whether the Medigen vaccine would be recognized by foreign countries, they did not care.
Even though they now have limited options to travel, they are not resentful of Medigen. They support Taiwan and are proud that a local company developed a COVID-19 vaccine. They should be applauded.
If Medigen covers their PCR test fees to recognize their trust in the company, it would be a moving story worth telling.
BUSINESS INCENTIVES
It would also be hugely beneficial to Medigen’s image. Business is business, and companies need to make money. Even so, Medigen would benefit from paying for the PCR tests.
First, Medigen would be given nationwide coverage, which would be “free” advertising. Second, it would restore Medigen’s reputation and win the trust of more people.
“Business reputation is above everything,” an official said when asked about insurance companies that have incurred great losses over COVID-19 insurance policies.
Compared with those losses, the costs of PCR tests would be negligible for Medigen.
If Medigen covers the testing fees, opposition parties might stop bad-mouthing the drugmaker. This would be of great help to the government and its officials who have supported Medigen. In turn, it would be advantageous for the drugmaker’s business development.
RECOGNIZING SUPPORT
Many of my friends have received the Medigen vaccine. They did so without hesitation, and their reason was simple: They love Taiwan, and they wish to contribute to the nation’s vaccine industry.
Although they might be unable to travel to Japan for now, many have remained faithful and are unfazed by the inconvenience. Nor have they asked for compensation from Medigen. Medigen should therefore cherish their support and appreciation, and act accordingly.
The financial losses are temporary, whereas a corporation’s reputation and people’s trust can go far.
Medigen will hopefully deal with the issue with sincerity and courage, and be determined to compensate recipients of the vaccine. Medigen should take the responsibility to pay for the PCR tests for their supporters who plan to visit Japan. It should announce this plan as soon as possible.
Tsai Jr-keng is a retired elementary-school principal.
Translated by Liu Yi-hung
On May 7, 1971, Henry Kissinger planned his first, ultra-secret mission to China and pondered whether it would be better to meet his Chinese interlocutors “in Pakistan where the Pakistanis would tape the meeting — or in China where the Chinese would do the taping.” After a flicker of thought, he decided to have the Chinese do all the tape recording, translating and transcribing. Fortuitously, historians have several thousand pages of verbatim texts of Dr. Kissinger’s negotiations with his Chinese counterparts. Paradoxically, behind the scenes, Chinese stenographers prepared verbatim English language typescripts faster than they could translate and type them
More than 30 years ago when I immigrated to the US, applied for citizenship and took the 100-question civics test, the one part of the naturalization process that left the deepest impression on me was one question on the N-400 form, which asked: “Have you ever been a member of, involved in or in any way associated with any communist or totalitarian party anywhere in the world?” Answering “yes” could lead to the rejection of your application. Some people might try their luck and lie, but if exposed, the consequences could be much worse — a person could be fined,
Xiaomi Corp founder Lei Jun (雷軍) on May 22 made a high-profile announcement, giving online viewers a sneak peek at the company’s first 3-nanometer mobile processor — the Xring O1 chip — and saying it is a breakthrough in China’s chip design history. Although Xiaomi might be capable of designing chips, it lacks the ability to manufacture them. No matter how beautifully planned the blueprints are, if they cannot be mass-produced, they are nothing more than drawings on paper. The truth is that China’s chipmaking efforts are still heavily reliant on the free world — particularly on Taiwan Semiconductor Manufacturing
Last week, Nvidia chief executive officer Jensen Huang (黃仁勳) unveiled the location of Nvidia’s new Taipei headquarters and announced plans to build the world’s first large-scale artificial intelligence (AI) supercomputer in Taiwan. In Taipei, Huang’s announcement was welcomed as a milestone for Taiwan’s tech industry. However, beneath the excitement lies a significant question: Can Taiwan’s electricity infrastructure, especially its renewable energy supply, keep up with growing demand from AI chipmaking? Despite its leadership in digital hardware, Taiwan lags behind in renewable energy adoption. Moreover, the electricity grid is already experiencing supply shortages. As Taiwan’s role in AI manufacturing expands, it is critical that
RSS